Loading…

Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐ κ B pathway

Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 2009-01, Vol.145 (3), p.385-396
Main Authors: Bardelli, Claudio, Gunella, Gabriele, Varsaldi, Federica, Balbo, Pietro, Del Boca, Elisa, Bernardone, Ilaria Seren, Amoruso, Angela, Brunelleschi, Sandra
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Substance P (SP) is deeply involved in lung pathophysiology and plays a key role in the modulation of inflammatory‐immune processes. We previously demonstrated that SP activates guinea‐pig alveolar macrophages (AMs) and human monocytes, but a careful examination of its effects on human AMs is still scarce. This study was undertaken to establish the role of SP in human AM isolated from healthy smokers and non‐smokers, by evaluating the presence of tachykinin NK 1 receptors (NK‐1R) and SP's ability to induce superoxide anion (O 2 − ) production and cytokine release, as well as activation of the nuclear factor‐ κ B (NF‐ κ B) pathway. By Western blot analysis and immunofluorescence, we demonstrate that authentic NK‐1R are present on human AMs, a three‐fold enhanced expression being observed in healthy smokers. These NK‐1R are functional, as SP and NK 1 agonists dose‐dependently induce O 2 − production and cytokine release. In AMs from healthy smokers, SP evokes an enhanced respiratory burst and a significantly increased release of tumor necrosis factor‐ α as compared to healthy non‐smokers, but has inconsistent effects on IL‐10 release. The NK 1 selective antagonist CP 96,345 ((2 S ,3 S )‐ cis ‐2‐diphenylmethyl‐ N [(2‐methoxyphenyl)‐methyl]‐1‐azabicyclo‐octan‐3‐amine)) competitively antagonized SP‐induced effects. SP activates the transcription factor NF‐ κ B, a three‐fold increased nuclear translocation being observed in AMs from healthy smokers. This effect is receptor‐mediated, as it is reproduced by the NK 1 selective agonist [Sar 9 Met(O 2 ) 11 ]SP and reverted by CP 96,345. These results clearly indicate that human AMs possess functional NK‐1R on their surface, which are upregulated in healthy smokers, providing new insights on the mechanisms involved in tobacco smoke toxicity. British Journal of Pharmacology (2005) 145 , 385–396. doi: 10.1038/sj.bjp.0706198
ISSN:0007-1188
1476-5381
DOI:10.1038/sj.bjp.0706198